Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence.

Yeh YC, Chen PJ, Lai MS.

JAMA. 2013 Feb 27;309(8):765-6. doi: 10.1001/jama.2013.571. No abstract available.

PMID:
23443430
2.

Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence.

Hsu CS.

JAMA. 2013 Feb 27;309(8):765. doi: 10.1001/jama.2013.568. No abstract available.

PMID:
23443429
3.

Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence--reply.

Wu CY, Hsu YC.

JAMA. 2013 Feb 27;309(8):766-7. doi: 10.1001/jama.2013.574. No abstract available.

PMID:
23443431
4.
5.

Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.

Xu J, Li J, Chen J, Liu ZJ.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):331-40. doi: 10.17219/acem/29760. Review.

6.

Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.

Zhang ZY, Zhou ZQ, Zhou GW.

Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1116-24. doi: 10.1097/MEG.0000000000000153.

PMID:
25003747
7.
8.

Recent advances in the prevention of hepatocellular carcinoma recurrence.

Lu LC, Cheng AL, Poon RT.

Semin Liver Dis. 2014 Nov;34(4):427-34. doi: 10.1055/s-0034-1394141. Epub 2014 Nov 4. Review.

PMID:
25369304
9.

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.

Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC.

Eur J Surg Oncol. 2012 Aug;38(8):683-91. doi: 10.1016/j.ejso.2012.04.010. Epub 2012 May 22.

PMID:
22621971
10.

Hepatitis B virus DNA and hepatocellular carcinoma recurrence after resection: the lower, the better!

You H, Jia JD.

J Gastroenterol Hepatol. 2010 Dec;25(12):1812-4. doi: 10.1111/j.1440-1746.2010.06516.x. No abstract available.

PMID:
21091989
11.

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.

Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.

J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.

PMID:
22011297
12.
13.

Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.

Llovet JM, Lok A.

J Natl Cancer Inst. 2008 Aug 20;100(16):1121-3. doi: 10.1093/jnci/djn261. Epub 2008 Aug 11. No abstract available.

14.

How does hepatitis B virus infection react to hepatocellular carcinoma treatment?

Wong GL.

J Gastroenterol Hepatol. 2012 Jan;27(1):1-2. doi: 10.1111/j.1440-1746.2011.06950.x. No abstract available.

PMID:
22188022
15.

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.

Li N, Lai EC, Shi J, Guo WX, Xue J, Huang B, Lau WY, Wu MC, Cheng SQ.

Ann Surg Oncol. 2010 Jan;17(1):179-85. doi: 10.1245/s10434-009-0694-z. Epub 2009 Aug 29.

PMID:
19727956
16.

[Ratio analysis of HBV-related liver disease and primary liver carcinoma development over 10 years in patients who received no antiviral therapy versus those treated with antiviral therapy].

Huo H, Ren S, Wang S, Xu Y, Ma L, Liu Y, Jin Y, Zheng Y, Chen X.

Zhonghua Gan Zang Bing Za Zhi. 2014 Jan;22(1):68-70. Chinese. No abstract available.

PMID:
24754089
17.

Preventing infection-associated cancer: from bench to hillside.

Goedert JJ.

J Natl Cancer Inst. 2005 Feb 16;97(4):245-6. No abstract available.

PMID:
15713953
18.

Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.

Viganò M, Bhoori S, Lampertico P, Donato MF, Iavarone M, Grossi G, Facciorusso A, Caccamo L, Rossi G, Colombo M, Mazzaferro V.

Liver Int. 2015 Sep;35(9):2187-93. doi: 10.1111/liv.12835. Epub 2015 Apr 21.

PMID:
25809541
19.

A message to Asia.

Suzuki H.

Oncology. 2002;62 Suppl 1:103-4. No abstract available.

PMID:
11868778
20.

Quiet reflection after effective action: hepatitis B viraemia and hepatocellular carcinoma recurrence.

Abdo AA, Sanai FM.

Liver Int. 2008 Apr;28(4):423-5. doi: 10.1111/j.1478-3231.2008.01731.x. No abstract available.

PMID:
18339067

Supplemental Content

Support Center